80 Kodiak Sciences Inc. Consolidated Balance Sheets (in thousands, except share and per share amounts) December 31, 2025 December 31, 2024 Assets Current assets: ........................................................................................... Cash and cash equivalents $ 209,862 $ 168,074 ...................................................................... Prepaid expenses and other current assets 4,954 3,862 ................................................................................................. Total current assets 214,816 171,936 ............................................................................................................... Restricted cash 6,184 6,184 ............................................................................................ Property and equipment, net 85,258 102,222 ..................................................................................... Operating lease right-of-use asset 36,606 46,508 .................................................................................................................... Other assets 8,669 8,728 ............................................................................................................ Total assets $ 351,533 $ 335,578 Liabilities and stockholders’ equity Current liabilities: ....................................................................................................... Accounts payable $ 12,863 $ 3,915 ............................................................................. Accrued and other current liabilities 20,607 11,030 ............................................................................................... Operating lease liability 12,063 10,628 ............................................................................................ Total current liabilities 45,533 25,573 ................................................................................... Long-term operating lease liability 47,117 59,717 ......................................................................... Liability related to sale of future royalties 100,000 100,000 .......................................................................................................... Long-term deposit 1,500 — ....................................................................................................... Total liabilities 194,150 185,290 Commitments and contingencies (Note 8) Stockholders’ equity: ............... Preferred stock, $0.0001 par value – 10,000,000 shares authorized; none issued — — .................................................. Common stock, $0.0001 par value – 490,000,000 shares authorized; 61,758,454 and 52,726,916 shares issued and outstanding, respectively 6 5 ................................................................................................ Additional paid-in capital 1,716,082 1,479,021 ........................................................................................................ Accumulated deficit (1,558,705) (1,328,738) ....................................................................................... Total stockholders’ equity 157,383 150,288 ................................................................... Total liabilities and stockholders’ equity $ 351,533 $ 335,578 See notes to consolidated financial statements.